Skip to main content

Aravinda de Silva

Aravinda de Silva, PhD, MPH, is a UNC Lineberger Comprehensive Cancer Center member who researches flaviviruses, particularly dengue, and also studies Zika.

PhD, MPH
Professor, Microbiology and Epidemiology
UNC-Chapel Hill
Immunology

Area of Interest

Aravinda de Silva, PhD, MPH, researches flaviviruses, particularly dengue, a mosquito-borne virus that, according to the World Health Organization, is “spreading explosively” in many parts of the world. Currently, more than half of the world’s population is at risk of infection by one or more of the four types of dengue, which can cause serious illness or a severe, life-threatening disease known as dengue hemorrhagic fever. The de Silva laboratory studies the basic virology, human immunology and pathogenesis of dengue.

de Silva also studies Zika. He is part of a team studying the epidemiology and effective diagnostics of the maternal-fetal transmission of Zika. de Silva has received National Institutes of Health support to work on a Zika vaccine.

Find publications on PubMed